Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
StateWatch Fall 2015
Workers' Comp
News Release
Genex Services Acquires CID Management
Deal creates an industry-leading technology solution and utilization review program in workers' comp July 31, 2015 – Wayne,
WorkCompCentral
In the News
Safety Council Calls for Employers and Insurers to Address Opioid Abuse
WorkCompWire
In the News
GENEX Services Acquires Case Management Firm ICM
Workers' Comp
News Release
Genex Services Acquires Leading Case Management Firm ICM
Combination of industry leaders will enhance excellence in managed care services June 30, 2015 – Wayne, Pa. —&nb
Workers' Comp
News Release
Heart of Giving
Genex Announces Case Manager Scholarship Award RecipientsJune 10, 2015 – Wayne, Pa.